The following analysts provide research coverage of Human Genome Sciences, Inc. (NASDAQ: HGSI).

Bank of America/Merrll Lynch
Rachel McMinn

  BernsteinResearch
Geoffrey C. Porges, MBBS

BMO Capital Markets
Jim Birchenough, M.D.

Brean Murray Carrett
Brian Skorney

Citigroup Investment Research
Yaron Werber, MD

Collins Stewart
Salveen J. Richter, CFA

Cowen and Company
Eric Schmidt, Ph.D.

Credit Suisse
Ravi Mehrotra, Ph.D.

Goldman, Sachs & Company
Terence Flynn, Ph.D.

ISI Group, Inc.
Mark Schoenebaum

JMP Securities
Liisa A. Bayko

JPMorgan
Cory Kasimov

Lazard Capital Markets
William Tanner

Leerink Swann
Joseph P. Schwartz

Monness, Crespi, Hardt & Company
Avik Roy

Morningstar Equity Research
Meera Venu

Piper Jaffray
M. Ian Somaiya

RBC Capital Markets
Michael Yee

R.W. Baird
Christopher J. Raymond

Stifel Nicolaus
Maged Shenouda

Summer Street Research
Carol Werther

ThinkEquity
Marko Kozul
 

Human Genome Sciences, Inc. ("HGS") makes no representation as to the accuracy or completeness of any of these analysts' reports. The projections and analysis therein are those of the authors of the reports, and are not endorsed by or on behalf of HGS and HGS does not undertake to update or correct any information contained therein. Factual information and opinions expressed in the reports are the responsibility of the author of the report and are subject to change.